The technology for manufacturing antiparasitic preparations. 4. the development of a technology for producing the anthelmintic bromoksan in finely dispersed form and the evaluation of its antifascioliasis activity
Mikhaĭlitsyn, F.S.; Petrov, I.F.; Bol'shakova, A.I.; Lebedeva, M.N.; Lychko, N.D.
Meditsinskaia Parazitologiia i Parazitarnye Bolezni 3: 41-42
1995
ISSN/ISBN: 0025-8326 PMID: 7476682 Document Number: 444174
A manufacturing procedure has been developed to prepare the anthelmintic bromoxane as a finely divided dosage form. The maximum toxic dose of the drug was 1 g per kg mice body weight. Its therapeutic dose in sheep fascioliasis was 20 mg/kg.
Document emailed within 1 workday
Related Documents
Mikhaĭlitsyn, F.S.; Drusviatskaia, S.K.; Uvarova, N.A.; Taits, S.Z.; Stoianovich, F.M.; Vol'kenshteĭn, I.B.; Lebedeva, M.N.; Krotov, A.I.; Lychko, N.D. 1994: The technology for manufacturing antiparasitic preparations. 3. the development of a technology for producing the anthelmintic embovin (pyrantel embonate) in finely dispersed form and the evaluation of its anthelmintic properties Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2: 24-26Kiseleva, I.A.; Anastasiev, V.V.; Novikova, L.P.; Voronova, E.A.; Kartavina, G.I. 1990: Elaboration of the technology of producing a lyophilized form of immunoglobulin preparations for intravenous administration Gematologiia i Transfuziologiia 35(5): 32-34
Barban, P.S. 1976: The complex technology of producing rickettsial diagnostic immunoglobulin preparations and comparative technico-economic indices Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 45-49
Jørgensen, M.S.; Jørgensen, U. 2009: Green technology foresight of high technology: a social shaping of technology approach to the analysis of hopes and hypes Technology Analysis-Strategic Management 21(3): 363-379
Mikhaĭlitsyn, F.S.; Lebedeva, M.N.; Baiandina, D.G.; Kozyreva, N.P.; Lychko, N.D.; Bolotina, L.A.; Drusviatskaia, S.K.; Naĭdenova, A.S. 1991: The search for new antiparasitic agents. 9. the anthelmintic activity of halogen-containing sulfonamidobenzamides Meditsinskaia Parazitologiia i Parazitarnye Bolezni 6: 52-53
Frieben, W.R.; Enzinger, R.M. 1992: Sterile product manufacturing technology Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 46(3): 85-86
Mikhaĭlitsyn, F.S.; Lebedeva, M.N.; Baiandina, D.G.; Dzhabarova, V.I.; Lychko, N.D.; Kozyreva, N.P.; Bolotina, L.A.; Naĭdenova, A.S. 1991: The search for new antiparasitic agents. 7. a study of the relationship between the structure and the anthelmintic activity of new halogen-containing benzamides Meditsinskaia Parazitologiia i Parazitarnye Bolezni 5: 53-55
Rodrigues, L.O.; Alves, T.P.; Cardoso, J.P.; Menezes, J.é C. 2006: Improving drug manufacturing with process analytical technology Idrugs: the Investigational Drugs Journal 9(1): 44-48
Mikhaĭlitsyn, F.S.; Kozyreva, N.P.; Veretennikova, N.L.; Lebedeva, M.N.; Pereverzeva, E.V.; Lychko, N.D. 1995: The search for new antiparasitic agents. 14. the synthesis, acute toxicity and anthelmintic activity of N-(3,5-dibromobenzo-2,1,3-thiadiazolyl-4)-2-[(4-ch lorophenylsulfonyl)amino]-5-bromobenzamide Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2: 30-32
Kurbatova, G.T.; Fedorenko, O.M.; Sokhov, S.T.; Verkholomova, I.; Shklovskaia, N.I. 1997: Distribution of anesthetics immobilized on finely dispersed iron powders in the organism of experimental animals Biofizika 42(6): 1292-1296
Dévay, A.; Schaffer, M.; Kovács, P.; Rácz, I. 1988: Application of a factorial experimental project for optimization of manufacturing technology for theophylline suppositories Acta Pharmaceutica Hungarica 58(5): 201-207
Mehansho, H.; Mellican, R.I.; Hughes, D.L.; Compton, D.B.; Walter, T. 2003: Multiple-micronutrient fortification technology development and evaluation: from lab to market Food and Nutrition Bulletin 24(4 Suppl): S111-S119
Gopienko, N.A. 1979: Experience in using electronic computer technology in the medical health unit of the Ufa Motor Building Manufacturing Association Zdravookhranenie Rossiiskoi Federatsii 1979(7): 27-30
Li, C.; Cai, Y.C.; Wang, W.; Li, Q.L.; Zhou, Y.Q.; Liu, J.F.; Shui, C.Y.; Huang, L.; Deng, M.; Zhu, G.Q.; Liu, K.; Wang, S.X.; Chen, J.; Sun, R.H. 2016: Reconstruct the complex defects of mandible individually by computer-aided design and manufacturing technology: a case report Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 51(10): 780-782
Arecco, D.; Bassi, M.; Gabrielli, B.; Merlini, A. 1976: Technology of pharmaceutic powders: tablets produced using a special technology Bollettino Chimico Farmaceutico 115(10): 680-701
Boitte, P 2005: Between technology and humanity: the impact of technology on health care ethics Journal of Medical Ethics 31(1): E4-E4
Wamuyu, P Kanyi 2015: The Impact of Information and Communication Technology Adoption and Diffusion on Technology Entrepreneurship in Developing Countries: The Case of Kenya Information Technology for Development 21(2): 253-280
Rothman, B.K. 1998: Ideology and technology: the social context of procreative technology Mount Sinai Journal of Medicine new York 65(3): 201-209; Discussion: 215-223
1983: Technology. Joint model for local agreement on new technology Sygeplejersken 83(7): 20-3 28
Hilleman, M.R.; Gerety, R.J.; Ellis, R.W. 1987: Concerns for the use of continuous cell lines and certain promoters for producing vaccine antigens by recombinant technology Developments in Biological Standardization 68: 5-7